Global Meningococcal Vaccines Market Size & Outlook
Global meningococcal vaccines market, 2021-2033 (US$M)
Related Markets
Global meningococcal vaccines market highlights
- The global meningococcal vaccines market generated a revenue of USD 4,054.7 million in 2025 and is expected to reach USD 5,961.7 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 4.5% by 2033.
- In terms of segment, menveo accounted for a revenue of USD 1,305.8 million in 2025.
- Nimenrix is the most lucrative brand segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, Thailand is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 4,054.7 million |
| Market revenue in 2033 | USD 5,961.7 million |
| Growth rate | 4.5% (CAGR from 2026 to 2033) |
| Largest segment | Menveo |
| Fastest growing segment | Nimenrix |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Menactra, Menveo, Nimenrix, Trumenba, Bexsero |
Other key industry trends
- In terms of revenue, the North America accounted for 55.2% of the global meningococcal vaccines market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, Thailand is the fastest growing regional market and is projected to reach USD 52.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Meningococcal Vaccines Market Scope
Meningococcal Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Walvax Biotechnology | View profile | 11-50 | Kunming, Yunnan, China, Asia | http://www.walvax.com |
| Serum Institute of India Pvt. Ltd. | View profile | 1001-5000 | Pune, Maharashtra, India, Asia | http://www.seruminstitute.com/ |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
Global meningococcal vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to meningococcal vaccines market will help companies and investors design strategic landscapes.
Menveo was the largest segment with a revenue share of 32.2% in 2025. Horizon Databook has segmented the Global meningococcal vaccines market based on menactra, menveo, nimenrix, trumenba, bexsero covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Meningococcal Vaccines Brand Outlook (Revenue, USD Million, 2021-2033)
- Menveo
- Others
- Bexsero
- Nimenrix
- Menactra
- Trumenba
- Global Meningococcal Vaccines Serotype Outlook (Revenue, USD Million, 2021-2033)
- W-135
- Y
- C
- A
- B
- Global Meningococcal Vaccines Age Group Outlook (Revenue, USD Million, 2021-2033)
- Infants (0 to 2 years)
- Children and Adults (2 years and above)
- Global Meningococcal Vaccines Sales Channel Outlook (Revenue, USD Million, 2021-2033)
- Public
- Private
- Global Meningococcal Vaccines Type Outlook (Revenue, USD Million, 2021-2033)
- Bivalent
- Quadrivalent
- Others
Reasons to subscribe to Global meningococcal vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global meningococcal vaccines market databook
-
Our clientele includes a mix of meningococcal vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global meningococcal vaccines market , including forecasts for subscribers. This global databook contains high-level insights into Global meningococcal vaccines market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global meningococcal vaccines market size, by regions, 2021-2033 (US$M)
Top 10 countries: Meningococcal vaccines market size, 2021 (US$M)
Global meningococcal vaccines market share, by brand, 2025 & 2033 (%, US$M)
Meningococcal vaccines market: Opportunity assessment by country
Global meningococcal vaccines market, by region, 2025 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
